Evidence map›Paper›PMID 26908260›Full record

ArticlePloS one2016

Molecular Characterization of Transgenic Events Using Next Generation Sequencing Approach.

Satish K Guttikonda, Pradeep Marri, Jafar Mammadov, Liang Ye, Khaing Soe, Kimberly Richey, James Cruse, Meibao Zhuang, Zhifang Gao, Clive Evans and 2 more

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Article
  2. Overexpression ofFrontiers in plant science · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Satish K GuttikondaDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, Indiana, 46268, United States of America.
Pradeep MarriDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, Indiana, 46268, United States of America.
Jafar MammadovDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, Indiana, 46268, United States of America.
Liang YeDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, Indiana, 46268, United States of America.
Khaing SoeDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, Indiana, 46268, United States of America.
Kimberly RicheyDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, Indiana, 46268, United States of America.
James CruseDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, Indiana, 46268, United States of America.
Meibao ZhuangDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, Indiana, 46268, United States of America.
Zhifang GaoDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, Indiana, 46268, United States of America.
Clive EvansDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, Indiana, 46268, United States of America.
Steve RounsleyDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, Indiana, 46268, United States of America.
Siva P KumpatlaDow AgroSciences LLC, 9330 Zionsville Road, Indianapolis, Indiana, 46268, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Demand for the commercial use of genetically modified (GM) crops has been increasing in light of the projected growth of world population to nine billion by 2050. A prerequisite of paramount importance for regulatory submissions is the rigorous safety assessment of GM crops. One of the components of safety assessment is molecular characterization at DNA level which helps to determine the copy number, integrity and stability of a transgene; characterize the integration site within a host genome; and confirm the absence of vector DNA. Historically, molecular characterization has been carried out using Southern blot analysis coupled with Sanger sequencing. While this is a robust approach to characterize the transgenic crops, it is both time- and resource-consuming. The emergence of next-generation sequencing (NGS) technologies has provided highly sensitive and cost- and labor-effective alternative for molecular characterization compared to traditional Southern blot analysis. Herein, we have demonstrated the successful application of both whole genome sequencing and target capture sequencing approaches for the characterization of single and stacked transgenic events and compared the results and inferences with traditional method with respect to key criteria required for regulatory submissions.

Indexed as

TransgenesBlotting, SouthernGene DosageGenomicsGlycine maxHigh-Throughput Nucleotide SequencingPlant BreedingPlants, Genetically Modified

Identifiers

PMID26908260
PMCPMC4764375

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.